Telavancin

Cat. No.: IBDI-433404

Telavancin (TD-6424) is a semisynthetic lipoglycopeptide vancomycin-derivative, is a novel antimicrobial agent developed by Theravance for overcoming resistant Gram-positive bacterial infections, specifically methicillin-resistant Staphylococcus aureus (MRSA). Telavancin disrupts cell membrane integrity, can be used for research of complicated skin and skin structure infections (cSSSIs) caused by Gram-positive bacteria.

Product Details

Target	Antibiotic | Bacterial
Molecular Weight	1755.63
Synonyms	TD-6424
SMILES	ClC1=CC([[email protected]]([[email protected]](C(N[[email protected]@H]2C(O)=O)=O)([H])N3)O)=CC=C1OC4=CC([[email protected]](NC([[email protected]@H](NC5=O)CC(N)=O)=O)([H])C(N[[email protected]](C3=O)([H])C(C=C6C(C2=CC(O)=C7CNC[P](O)(O)=O)=C7O)=CC=C6O)=O)=CC(OC8=CC=C([[email protected]]([[email protected]]5NC([[email protected]](NC)CC(C)C)=O)O)C=C8Cl)=C4O[[email protected]](O[[email protected]@H]9CO)[[email protected]@H]([[email protected]]([[email protected]@H]9O)O)O[[email protected]](O[[email protected]]%10C)C[[email protected]@](C)([[email protected]@H]%10O)NCCNCCCCCCCCCC

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.